Bypassing the periplasm: Reconstitution of the AcrAB multidrug efflux pump of Escherichia coli
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
AcrAB is a constitutively expressed, major multidrug efflux system of Escherichia coli . We have purified the cytoplasmic membrane component, AcrB, to near homogeneity, and reconstituted the protein into proteoliposomes. In the presence of ΔpH (outside acid), the protein catalyzed the extrusion of fluorescent phospholipids, which were then trapped by protein-free acceptor vesicles. Known substrates of AcrAB, such as bile acids, erythromycin, and cloxacillin, inhibited this activity. Addition of various drugs to AcrB-containing proteoliposomes, in the presence of ΔpH (inside acid) resulted in proton efflux, suggesting that AcrB is a proton antiporter. Interestingly, fluorescent lipid extrusion was accelerated strongly by the periplasmic protein AcrA in the presence of Mg 2+ , and at pH 5.0 AcrA alone produced a slow mixing of lipids of different vesicles, without causing the mixing of intravesicular material. These results suggest that AcrA brings two membranes together, and under certain conditions may even cause the fusion of at least the outer leaflets of the membranes, contributing to the ability of the AcrAB–TolC system to pump drugs out directly into the medium.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
[10] Assay of inorganic phosphate, total phosphate and phosphatases
Ames, B. N. (1966) · Methods in Enzymology · doi:10.1016/0076-6879(66)08014-5 · Cited by 3,337
A rapid, sensitive, and specific method for the determination of protein in dilute solution
Schaffner, W., & Weissmann, C. (1973) · Analytical Biochemistry · doi:10.1016/0003-2697(73)90217-0 · Cited by 2,509
Use of resonance energy transfer to monitor membrane fusion
Struck, D. K., Hoekstra, D., & Pagano, R. E. (1981) · Biochemistry · doi:10.1021/bi00517a023 · Cited by 1,277
Multidrug efflux pumps of gram-negative bacteria
Nikaido, H. (1996) · Journal of Bacteriology · doi:10.1128/jb.178.20.5853-5859.1996 · Cited by 1,082
Self-citationOkusu, H., Ma, D., & Nikaido, H. (1996) · Journal of Bacteriology · doi:10.1128/jb.178.1.306-308.1996 · Cited by 814
Self-citationGenes acrA and acrB encode a stress‐induced efflux system of Escherichia coli
Ma, D., Cook, D. N., Alberti, M., Pon, N. G., Nikaido, H., & Hearst, J. E. (1995) · Molecular Microbiology · doi:10.1111/j.1365-2958.1995.tb02390.x · Cited by 602
Self-citationPhosphatidylcholine translocase: A physiological role for the mdr2 gene
Ruetz, S. (1994) · Cell · doi:10.1016/0092-8674(94)90446-4 · Cited by 599
Fluorescent cellular indicators are extruded by the multidrug resistance protein.
Homolya, L., Holló, Z., Germann, U. A., Pastan, I., Gottesman, M. M., & Sarkadi, B. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80566-3 · Cited by 495
Lipid-anchored influenza hemagglutinin promotes hemifusion, not complete fusion
Kemble, G. W., Danieli, T., & White, J. M. (1994) · Cell · doi:10.1016/0092-8674(94)90344-1 · Cited by 479
Active efflux of bile salts by Escherichia coli
Thanassi, D. G., Cheng, L. W., & Nikaido, H. (1997) · Journal of Bacteriology · doi:10.1128/jb.179.8.2512-2518.1997 · Cited by 471
Self-citation
Cited by
Molecular Basis of Bacterial Outer Membrane Permeability Revisited
Nikaido, H. (2003) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.67.4.593-656.2003 · Cited by 4,316
“coli [776] and MDR1, which is highly expressed in the apical membranes of intestinal cells [656]).”
BackgroundSelf-citationMultidrug Resistance in Bacteria
Nikaido, H. (2009) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.78.082907.145923 · Cited by 1,682
Self-citationThe Challenge of Efflux-Mediated Antibiotic Resistance in Gram-Negative Bacteria
Li, X.-Z., Plésiat, P., & Nikaido, H. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00117-14 · Cited by 1,614
Self-citationEfflux-mediated heavy metal resistance in prokaryotes
Nies, D. H. (2003) · FEMS Microbiology Reviews · doi:10.1016/s0168-6445(03)00048-2 · Cited by 1,557
Structure of a bacterial multidrug ABC transporter
Dawson, R. J. P., & Locher, K. P. (2006) · Nature · doi:10.1038/nature05155 · Cited by 1,279
Koronakis, V., Sharff, A., Koronakis, E., Luisi, B., & Hughes, C. (2000) · Nature · doi:10.1038/35016007 · Cited by 1,086
Crystal structure of bacterial multidrug efflux transporter AcrB
Murakami, S., Nakashima, R., Yamashita, E., & Yamaguchi, A. (2002) · Nature · doi:10.1038/nature01050 · Cited by 986
Efflux-Mediated Drug Resistance in Bacteria: An Update
Li, X.-Z., & Nikaido, H. (2009) · Drugs · doi:10.2165/11317030-000000000-00000 · Cited by 966
Self-citationLomovskaya, O., Warren, M. S., Lee, A., Galazzo, J., Fronko, R., Lee, M., Blais, J., Cho, D., Chamberland, S., Renau, T., et al. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.1.105-116.2001 · Cited by 903
Multiple molecular mechanisms for multidrug resistance transporters
Higgins, C. F. (2007) · Nature · doi:10.1038/nature05630 · Cited by 860
A Functional-Phylogenetic Classification System for Transmembrane Solute Transporters
Saier, M. H. (2000) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.64.2.354-411.2000 · Cited by 826
Efflux-Mediated Drug Resistance in Bacteria
Li, X.-Z., & Nikaido, H. (2004) · Drugs · doi:10.2165/00003495-200464020-00004 · Cited by 798
Self-citationMolecular Properties of Bacterial Multidrug Transporters
Putman, M., van Veen, H. W., & Konings, W. N. (2000) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.64.4.672-693.2000 · Cited by 795
Mechanisms of Solvent Tolerance in Gram-Negative Bacteria
Ramos, J. L., Duque, E., Gallegos, M.-T., Godoy, P., Ramos-González, M. I., Rojas, A., Terán, W., & Segura, A. (2002) · Annual Review of Microbiology · doi:10.1146/annurev.micro.56.012302.161038 · Cited by 791
Crystal structures of a multidrug transporter reveal a functionally rotating mechanism
Murakami, S., Nakashima, R., Yamashita, E., Matsumoto, T., & Yamaguchi, A. (2006) · Nature · doi:10.1038/nature05076 · Cited by 773
Analysis of a Complete Library of Putative Drug Transporter Genes in Escherichia coli
Nishino, K., & Yamaguchi, A. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.20.5803-5812.2001 · Cited by 666
Permeability Barrier of Gram-Negative Cell Envelopes and Approaches To Bypass It
Zgurskaya, H. I., López, C. A., & Gnanakaran, S. (2015) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.5b00097 · Cited by 580
Self-citationMechanisms of RND multidrug efflux pumps
Nikaido, H., & Takatsuka, Y. (2009) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2008.10.004 · Cited by 555
Self-citationOutten, F. W., Huffman, D. L., Hale, J. A., & O'Halloran, T. V. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104122200 · Cited by 544
Nicolaou, S. A., Gaida, S. M., & Papoutsakis, E. T. (2010) · Metabolic Engineering · doi:10.1016/j.ymben.2010.03.004 · Cited by 538
Bacterial resistance to antibiotics: Active efflux and reduced uptake
KUMAR, A., & SCHWEIZER, H. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.04.004 · Cited by 529
Multidrug Pump Inhibitors Uncover Remarkable Activity of Plant Antimicrobials
Tegos, G., Stermitz, F. R., Lomovskaya, O., & Lewis, K. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.10.3133-3141.2002 · Cited by 517
Rosenberg, E. Y., Bertenthal, D., Nilles, M. L., Bertrand, K. P., & Nikaido, H. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03531.x · Cited by 468
Self-citationMultidrug resistance mechanisms: drug efflux across two membranes
Zgurskaya, H. I., & Nikaido, H. (2000) · Molecular Microbiology · doi:10.1046/j.1365-2958.2000.01926.x · Cited by 466
Self-citationInteractions between Bacteria and Bile Salts in the Gastrointestinal and Hepatobiliary Tracts
Urdaneta, V., & Casadesús, J. (2017) · Frontiers in Medicine · doi:10.3389/fmed.2017.00163 · Cited by 449
Type I secretion in gram-negative bacteria
Delepelaire, P. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2004.05.001 · Cited by 410
Structural Basis of Multiple Drug-Binding Capacity of the AcrB Multidrug Efflux Pump
Yu, E. W., McDermott, G., Zgurskaya, H. I., Nikaido, H., & Koshland, D. E. (2003) · Science · doi:10.1126/science.1083137 · Cited by 392
Self-citationEfflux-Mediated Resistance to Fluoroquinolones in Gram-Negative Bacteria
Poole, K. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.9.2233-2241.2000 · Cited by 371
Contribution of the Mycobacterium tuberculosis MmpL Protein Family to Virulence and Drug Resistance
Domenech, P., Reed, M. B., & Barry, C. E. (2005) · Infection and Immunity · doi:10.1128/iai.73.6.3492-3501.2005 · Cited by 361
Mechanisms of bacterial resistance and response to bile
Gunn, J. S. (2000) · Microbes and Infection · doi:10.1016/s1286-4579(00)00392-0 · Cited by 323
Preventing drug access to targets: cell surface permeability barriers and active efflux in bacteria
Nikaido, H. (2001) · Seminars in Cell & Developmental Biology · doi:10.1006/scdb.2000.0247 · Cited by 317
Self-citationDrug transport mechanism of the AcrB efflux pump
Pos, K. M. (2009) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2008.12.015 · Cited by 310
Elkins, C. A., & Nikaido, H. (2002) · Journal of Bacteriology · doi:10.1128/jb.184.23.6490-6499.2002 · Cited by 303
Self-citationConformational Flexibility in the Multidrug Efflux System Protein AcrA
Mikolosko, J., Bobyk, K., Zgurskaya, H. I., & Ghosh, P. (2006) · Structure · doi:10.1016/j.str.2005.11.015 · Cited by 279
Self-citationStructure and function of efflux pumps that confer resistance to drugs
BORGES-WALMSLEY, M. I., McKEEGAN, K. S., & WALMSLEY, A. R. (2003) · Biochemical Journal · doi:10.1042/bj20020957 · Cited by 278
Multidrug resistance in Gram-negative bacteria
Poole, K. (2001) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(00)00242-3 · Cited by 275
An allosteric transport mechanism for the AcrAB-TolC multidrug efflux pump
Wang, Z., Fan, G., Hryc, C. F., Blaza, J. N., Serysheva, I. I., Schmid, M. F., Chiu, W., Luisi, B. F., & Du, D. (2017) · eLife · doi:10.7554/elife.24905 · Cited by 275
AcrA, AcrB, and TolC of Escherichia coli Form a Stable Intermembrane Multidrug Efflux Complex
Tikhonova, E. B., & Zgurskaya, H. I. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402230200 · Cited by 270
Self-citationRecent advances toward a molecular mechanism of efflux pump inhibition
Opperman, T. J., & Nguyen, S. T. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00421 · Cited by 266
Structure, function and inhibition of RND efflux pumps in Gram-negative bacteria: an update
Blair, J. M., & Piddock, L. J. (2009) · Current Opinion in Microbiology · doi:10.1016/j.mib.2009.07.003 · Cited by 266
Structure of the periplasmic component of a bacterial drug efflux pump
Higgins, M. K., Bokma, E., Koronakis, E., Hughes, C., & Koronakis, V. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400375101 · Cited by 254
The AcrAB-TolC efflux system of Salmonella enterica serovar Typhimurium plays a role in pathogenesis
Buckley, A. M., Webber, M. A., Cooles, S., Randall, L. P., La Ragione, R. M., Woodward, M. J., & Piddock, L. J. V. (2006) · Cellular Microbiology · doi:10.1111/j.1462-5822.2005.00671.x · Cited by 231
“AcrB is an integral membrane protein with 12 membrane spanning α -helices, located in the cytoplasmic membrane (Zgurskaya and Nikaido, 1999).”
BackgroundKlebba, P. E., Newton, S. M. C., Six, D. A., Kumar, A., Yang, T., Nairn, B. L., Munger, C., & Chakravorty, S. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c01005 · Cited by 150
Metadata
- Authors
- Zgurskaya, H. I., & Nikaido, H.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1999-06-22
- Volume
- 96
- Issue
- 13
- Pages
- 7190-7195
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2016075837
- Cited by
- 360
- References
- 29
- FWCI
- 8.29
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.